{"organizations": [], "uuid": "7dc36d6e1c2daee8957967ebe02da660adbfb6a6", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "https://www.reuters.com/finance/markets/europe", "section_title": "European Stock Market News | Reuters.com", "url": "https://www.reuters.com/article/brief-basilea-pharmaceutica-reports-clin/brief-basilea-pharmaceutica-reports-clinical-phase-3-study-start-with-antibiotic-ceftobiprole-in-skin-infections-idUSFWN1QC1G1", "country": "US", "domain_rank": 408, "title": "BRIEF-Basilea Pharmaceutica Reports Clinical Phase 3 Study Start With Antibiotic Ceftobiprole In Skin Infections", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.987, "site_type": "news", "published": "2018-02-23T14:18:00.000+02:00", "replies_count": 0, "uuid": "7dc36d6e1c2daee8957967ebe02da660adbfb6a6"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-basilea-pharmaceutica-reports-clin/brief-basilea-pharmaceutica-reports-clinical-phase-3-study-start-with-antibiotic-ceftobiprole-in-skin-infections-idUSFWN1QC1G1", "ord_in_thread": 0, "title": "BRIEF-Basilea Pharmaceutica Reports Clinical Phase 3 Study Start With Antibiotic Ceftobiprole In Skin Infections", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "basilea pharmaceutica ag", "sentiment": "negative"}, {"name": "eikon", "sentiment": "none"}, {"name": "gdynia newsroom", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Feb 23 (Reuters) - BASILEA PHARMACEUTICA AG:‍​\n* REPORTS CLINICAL PHASE 3 STUDY START WITH ANTIBIOTIC CEFTOBIPROLE IN SKIN INFECTIONS Source text for Eikon: Further company coverage: (Gdynia Newsroom)\n ", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-02-23T14:18:00.000+02:00", "crawled": "2018-02-23T08:24:48.005+02:00", "highlightTitle": ""}